KüçükukurMBiniciR.Prognostic value of FIB-4 index and non-alcoholic fatty liver disease in myocardial infarction with non-obstructive coronary arteries. Angiology. 2026. In press.
2.
Tamis-HollandJEJneidHReynoldsHR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139(18):e891-e908.
3.
SterlingRKLissenEClumeckN, et al. Development of a simple noninvasive index to predict significant fibrosis. Hepatology. 2006;43:1317-1325.
4.
AydınCEmlekNErgülE.Liver fibrosis scores and coronary artery ectasia. Kardiologiia. 2023;63(7):62-67.
5.
NewsomePNSassoMDeeksJJ, et al. FibroScan-AST score for non-invasive identification of steatohepatitis. Lancet Gastroenterol Hepatol. 2020;5:362-373.
6.
ZhangLXuXZhangXJiangSHuiP.Systemic immune-inflammation index and cardiovascular outcomes. J Clin Ultrasound. 2024;52:295-304.
7.
AydınCEnginM.The value of inflammation indexes in predicting patency of saphenous vein grafts in patients with coronary artery bypass graft surgery. Cureus. 2021;13(7):e16646.
8.
AydinCAlpsoyŞAkyüzA, et al. Could the systemic immune-inflammation index be a predictor to estimate cerebrovascular events in hypertensive patients?Blood Press Monit. 2022;27(1):33-38.
